HRD CANCER

Clinical trials for HRD CANCER explained in plain language.

Never miss a new study

Get alerted when new HRD CANCER trials appear

Sign up with your email to follow new studies for HRD CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for cancers that resist standard treatments

Disease control Recruiting now

This study is testing whether combining two drugs can help people with aggressive cancers that have stopped responding to standard treatments. It focuses on small cell lung cancer and other cancers with specific genetic weaknesses that have become resistant to previous drugs. The…

Matched conditions: HRD CANCER

Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 25, 2026 14:08 UTC

HRD CANCER

Get alerted when new HRD CANCER trials appear

New hope for cancers that resist standard treatments